As of 2026-01-02, the Relative Valuation of AxoGen Inc (AXGN) is (1.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.73 USD, the upside of AxoGen Inc based on Relative Valuation is -104.6%.
The range of the Relative Valuation is (1.54) - (1.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 33.9x - 35.9x | 35.1x |
| Forward P/E multiples | 30.6x - 33.1x | 31.4x |
| Fair Price | (1.54) - (1.50) | (1.51) |
| Upside | -104.7% - -104.6% | -104.6% |
| Date | P/E |
| 2025-12-31 | -723.36 |
| 2025-12-30 | -719.84 |
| 2025-12-29 | -735.68 |
| 2025-12-26 | -721.38 |
| 2025-12-24 | -717.86 |
| 2025-12-23 | -722.26 |
| 2025-12-22 | -720.06 |
| 2025-12-19 | -703.35 |
| 2025-12-18 | -697.19 |
| 2025-12-17 | -690.37 |
| 2025-12-16 | -645.50 |
| 2025-12-15 | -654.96 |
| 2025-12-12 | -668.38 |
| 2025-12-11 | -659.36 |
| 2025-12-10 | -660.02 |
| 2025-12-09 | -673.22 |
| 2025-12-08 | -677.17 |
| 2025-12-05 | -732.82 |
| 2025-12-04 | -722.59 |
| 2025-12-03 | -623.07 |
| 2025-12-02 | -609.00 |
| 2025-12-01 | -627.47 |
| 2025-11-28 | -630.11 |
| 2025-11-26 | -627.91 |
| 2025-11-25 | -622.85 |
| 2025-11-24 | -624.39 |
| 2025-11-21 | -590.96 |
| 2025-11-20 | -564.57 |
| 2025-11-19 | -555.55 |
| 2025-11-18 | -528.06 |
| 2025-11-17 | -518.38 |
| 2025-11-14 | -517.94 |
| 2025-11-13 | -528.72 |
| 2025-11-12 | -529.82 |
| 2025-11-11 | -537.96 |
| 2025-11-10 | -527.84 |
| 2025-11-07 | -518.38 |
| 2025-11-06 | -527.62 |
| 2025-11-05 | -514.20 |
| 2025-11-04 | -522.78 |
| 2025-11-03 | -511.34 |
| 2025-10-31 | -488.69 |
| 2025-10-30 | -498.81 |
| 2025-10-29 | -489.35 |
| 2025-10-28 | -397.64 |
| 2025-10-27 | -390.82 |
| 2025-10-24 | -399.62 |
| 2025-10-23 | -396.98 |
| 2025-10-22 | -396.98 |
| 2025-10-21 | -384.66 |